Monday, March 03, 2025 | 09:28 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 2 - Pharamaceutical Industries

Pharma marketing practices: High-level committee to meet industry on Friday

The UCPMP is voluntary and there is no legal penalty for violating the code

Pharma marketing practices: High-level committee to meet industry on Friday
Updated On : 03 Nov 2022 | 9:59 PM IST

Wockhardt likely to sell India business to cut debt, focus on UK: Analysts

Company left with low-margin brands in India after selling profitable ones

Wockhardt likely to sell India business to cut debt, focus on UK: Analysts
Updated On : 21 Oct 2022 | 3:26 PM IST

Govt launches diabetes drug Sitagliptin, its combinations at Rs 60 per pack

The government on Friday launched diabetes drug Sitagliptin and its combinations at rates as low as Rs 60 per pack of ten, which will be sold at generic pharmacy stores, Janaushadhi Kendras. The Pharmaceuticals & Medical Devices Bureau of India (PMBI) has included new variants of Sitagliptin and its combination across its Jan Aushdhi Kendras, the Ministry of Chemicals and Fertilisers said in a statement. The maximum retail price for a pack of ten Sitagliptin phosphate tablets 50 mg is Rs 60, while the same for Sitagliptin phosphate tablet 100 mg is Rs 100. Combination of Sitagliptin and Metformin Hydrochloride tablets of 50mg/500mg is priced at Rs 65 for a pack of ten and Sitagliptin Metformin hydrochloride tablets of 50mg/1000mg strength comes for Rs 70 for the same quantity. "All these variants are available at 60 per cent to 70 per cent lesser prices than branded variants as they are available in price band of Rs 162 to Rs 258 at other medical stores," the statement said. PMBI

Govt launches diabetes drug Sitagliptin, its combinations at Rs 60 per pack
Updated On : 16 Sep 2022 | 5:43 PM IST
Updated On : 20 Aug 2022 | 5:48 PM IST

Bharat Biotech says Phase 3 trial over, intranasal vaccine 'safe'

The Hyderabad-based company claimed that BBV154 is proven to be safe, well-tolerated and immunogenic in the subjects under controlled clinical trials

Bharat Biotech says Phase 3 trial over, intranasal vaccine 'safe'
Updated On : 15 Aug 2022 | 11:10 PM IST

AP EAMCET Agriculture 2022 answer key released- here's how you can check

More than 200,000 candidates appeared for the AP EAPCET exam this year

AP EAMCET Agriculture 2022 answer key released- here's how you can check
Updated On : 13 Jul 2022 | 3:01 PM IST

AIMIL Pharma launches ayurveda-based beauty product

The product -- Ayouthveda -- has been prepared by adding time-tested herbs

AIMIL Pharma launches ayurveda-based beauty product
Updated On : 19 Nov 2021 | 10:00 PM IST

Dr Reddy's Lab receives USFDA approval to market Lenalidomide capsule

Dr Reddy's Laboratories on Tuesday said it has received approval from the US health regulator to market Lenalidomide capsules

Dr Reddy's Lab receives USFDA approval to market Lenalidomide capsule
Updated On : 19 Oct 2021 | 4:04 PM IST

Over 300 pharma, healthcare companies eligible for new Covid loans: Crisil

Hospitals to gain most with up to 3.5% dip on cost of funds; may add half a million beds, says rating agency

Over 300 pharma, healthcare companies eligible for new Covid loans: Crisil
Updated On : 07 May 2021 | 10:24 PM IST

Companies announce clinical trials for vaccine against China virus

At least four companies say they are working 'very rapidly' to find a vaccine.

Companies announce clinical trials for vaccine against China virus
Updated On : 24 Jan 2020 | 9:21 AM IST

From Zinetac to Calpol, top 10 drugs drive India revenue for big firms

Experts expect change in strategy for a focus on high-margin products, rather than multiple brand launches

From Zinetac to Calpol, top 10 drugs drive India revenue for big firms
Updated On : 31 Dec 2018 | 2:03 AM IST

The cost of cheap drugs? Toxic Indian lake is 'superbug hotspot'

Drugmakers in Medak, including large Indian firms Dr Reddy's Laboratories, Aurobindo Pharma and Hetero Drugs

The cost of cheap drugs? Toxic Indian lake is 'superbug hotspot'
Updated On : 29 Sep 2016 | 10:10 AM IST

Pharma sector raises concerns over proposed incentives cut

Union government is allegedly cutting down support to bulk drug manufacturing from a proposed outlay of Rs 5,000 crore to nearly Rs 600 crore

Pharma sector raises concerns over proposed incentives cut
Updated On : 08 Sep 2016 | 7:36 PM IST